Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
Douglas D. Fraser(Western University), Claúdia C. dos Santos(St. Michael's Hospital), Gediminas Cepinskas(Western University), David B. O’Gorman(Western University), Claudio M. Martin(Western University), Eric K. Patterson(Lawson Health Research Institute), Mark Daley(Western University), Sean E. Gill(Western University), Marat Slessarev(Western University), Michael R. Miller(Western University)
Cited by 114
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597